A US Senate bill to specifically allow the use of CBD and other hemp derivatives in dietary supplements and foods has been introduced with bipartisan sponsorship. The bill also enjoys broad support within the industry.
A marketer of CBD products has agreed in a Federal Trade Commission administrative proceeding to cease making unsubstantiated disease treatment claims and pay more than $30,000 in consumer redress.
CBD products manufacturer CV Sciences has recorded a sharp decline in revenue, mirroring reports of an overall contraction in the market for hemp extract products.
Consumer demand for CBD products has soared during lockdown, according to the Association for the Cannabinoid Industry (ACI), which estimates the sector will generate £690 million in annual sales this year, above a previous forecast of £526 million.
In a sign of further consolidation within the CBD/hemp products industry, THC Farmaceuticals Inc has announced it has acquired a contract manufacturer in Southern California.
Many of us know that valerian root, ashwagandha, chamomile and melatonin are helpful in delivering a good night’s rest. But how about CBN? Stuart Titus, PhD, CEO and president at Medical Marijuana, said that cannabinol hasn't really been available...
Proposed modernizations to the Dietary Supplement Health and Education Act (DSHEA) and solutions to the CBD issue require “an outstanding effort by industry to speak with a united voice”, says Loren Israelsen, President of the United Natural Products...
A report from a watchdog group found found that just 42% of CBD brands tested all their products for potency. Additionally, the vast majority of products tested were outside the limits of acceptable variance.
While AHPA supports H.R.841, the association wishes FDA “would do its job and establish a legal pathway [for hemp and CBD], but they haven’t,” said Michael McGuffin. “Something needs to happen.”
The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act represents ‘the best way’ to deal with the hemp-CBD issue for dietary supplements, says CRN’s Steve Mister, and once that’s clarified then the FDA and industry can address...
Fish oils supplier KD Pharma has moved more aggressively into the cannabinoid space with the acquisition of the manufacturing assets of a Swiss CBD and phyotextract specialist firm, the company announced today.
Two professional rugby players have created a startup selling third-party tested CBD supplements that give elite athletes and everyday consumers peace of mind over cannabinoid content
HempFusion, a manufacturer of CBD-containing ingestible and topical products, said a successful initial public offering and a refocus of its digital sales efforts will position the brand to become one of the major hemp/CBD players in 2021.
Texas delivery technology development firm Santé Laboratories is opening up its cannabinoid delivery system to brand holders. The approach has been validated with a direct to consumer control brand called RESET Bioscience.
Imagine taking the time and effort to cultivate hemp across hundreds of acres, only to find out that your harvest is contaminated. The damage can cause an odor, spoilage or significant illness to the end user if left unchecked.
Efforts to move the needle on hemp-CBD at the Federal level are slow, and upcoming exits of key personnel at FDA are unlikely to affect progress much, says NPA’s Dr Daniel Fabricant. “In some ways I think FDA likes the status quo,” he tells NutraIngredients-USA.
Before her foray into the botanical wellness industry, Amanda Jones spent two decades traveling the world as a journalist for Vogue Magazine. While it may sound like a luxurious position, Jones' work also put her up close and personal with women...
From respiratory support to superfoods, oral health to UTI defense, March showed up and showed out with supplements for just about anything the year throws at you.
The state of Colorado aims to remain a leader in the hemp industry, Gov. Jared Polis said at an industry event last week. He announced the release of a detailed state plan for the industry at the meeting, which includes scientific support, data sharing,...
The CBD/hemp markets, both in finished goods and on the supply side, are in a state of transition, attendees at an industry event learned on Friday. The message was that some growers and some finished product marketers are likely to fall by the wayside...
Colorado-based ValidCare has announced the preliminary findings from its industry-sponsored, decentralized human safety study of hemp derived CBD products, with the data indicating no liver toxicity.
A UK-based CBD and hemp supplier has inked a deal with a prominent mixed martial arts organization, a move that underscores fighters and MMA organizations normalizing and embracing the use of CBD.
Folium Biosciences has become another US-based firm to submit a Novel Foods application to the UK for its cannabidiol (CBD)-based oil in response to the 31 March deadline set by the country’s food authority.
The FSA (Food Standards Agency) has backtracked on its initial expectation for companies to make their novel foods applications at least five weeks in advance of the deadline and confirmed that it will accept applications up until March 31st, after receiving...
Yesterday the Natural Products Association testified in favor of a California bill to regulate the CBD trade in that state. NPA and others, however, have reiterated a call for federal legislation that would forestall the growing patchwork quilt of state...
Recent news reports about the marketing of products featuring Delta-8 THC as a prominent constituent have muddied the waters enough that the US Hemp Roundtable felt it necessary to clarify again what should—and shouldn’t—be called a hemp product.
Canopy Growth Corporation is entering the ‘high-potential US CBD beverage category’ with its premium ready-to-drink CBD-infused sparkling water Quatreau.
Many UK CBD brands have been misled on how to prepare for the looming novel foods deadline meaning there is less than one month for some to pull together potentially impossible amounts of data, an industry expert has warned.
Arcadia Biosciences recently announced that four of its varieties have passed the rigorous standards of the national Association of Official Seed Certifying Agencies (AOSCA) variety review board.
The National Football League and its players are seeking information from researchers on the use of CBD for pain relief. The hope is to lessen the use of opiates for the purpose.
From an electrolyte formula for dogs to a nutritional drink with nostalgic childhood vibes, February launches are a mixed bag of beverages, powders, chews...and even chocolate.
The US Hemp Authority has released the latest version of its certification standard whose aim is to promote best practices and heighten transparency among hemp companies.
Mirroring the human dietary supplement category, sales of pet supplements also skyrocketed in 2020, with Packaged Facts reporting that growth rates quadrupling in 2020 from 2019.
The study marks the first time humans were included in a peer-reviewed investigation of commercially available CBD product pharmacokinetics. Previous CBD studies have generally based their claims on animal model studies.
Guelph-based Nutrasource Pharmaceutical and Nutraceutical Services has received approval for an official Institution-Wide Cannabis Research License, paving the way for human research on cannabis and cannabis-derived compounds.
The company that specializes in liposomal delivery systems says it intends to disrupt the CBD beverage industry via its patent-pending nanoemulsion delivery technology.
The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act has been re-introduced in the US House of Representatives with the aim of making hemp and hemp-derived CBD a dietary ingredient in dietary supplements.
New users of dietary supplements – and increased usage among established consumers – are predicted to stay with the category after the pandemic subsides, according to industry CEOs.
The White House Office of Management and Budget pulled six FDA guidances and rules from its review, including the proposal "Cannabidiol Enforcement Policy; Draft Guidance for Industry" — handing the CBD industry yet another setback.
